This antibody specifically recognises Sialyl Lewis a-containing glycolipids. The epitope recognised is designated CA19-9.
Applications
IHC-P, IHC-Fr
Positive Control
Human skin.
Dilutions
IHC: 1:200 for 60 minutes at 25°C. High temperature antigen unmasking technique. Standard ABC technique.
Reactivity
Human
Cross Reactivity
This antibody displays minimal cross-reactivity (<1%) with Sialyl Lacto-N-tetraosylceramide. This antibody does not cross-react with Lewis a, Lewis b, or other structurally related molecules.
Immunogen
Human colorectal adenocarcinoma cell line COLO 205.
Host
Mouse
Clonality
Monoclonal
Clone ID
C241:5:1:4
Myeloma
Sp 2/0
Isotype
IgG1
Conjugate
Unconjugated
Purification
Affinity purification.
Concentration
Lot Specific
Product Form
Liquid
Formulation
Supplied in Phosphate Buffered Saline with 1% Bovine Serum Albumin and 15 mM Sodium Azide.
Storage
Shipped at 4°C. Store at 4°C. Do not freeze! Prepare working dilutions on the day of use.
Synonyms
CA19.9, Ovarian tumor antigen, Pancreatic tumor antigen, Sialyl Lewis a
Immunohistochemical analysis of colonic adenocarcinoma using Anti-CA19-9 Antibody [C241:5:1:4] (A320630). Note: The enhancement of the luminal membrane staining of colonic epithelial cells.
Publishing research using Anti-CA19-9 Antibody [C241:5:1:4] (A320630)? Please let us know so that we can list the citation on this page.
Alternative products to Anti-CA19-9 Antibody [C241:5:1:4] (A320630)